1911 GOLD ANNOUNCES OUTCOME OF TSX VENTURE EXCHANGE APPEAL
1911 Gold Corporation (‘1911 Gold’ or the ‘Company’) (TSXV: AUMB; OTCQB: AUMBF; FRA: 2KY) announces that after an appeal process (as announced...
Standard Uranium Outlines 2026 Exploration Plans and Highlights Successful 2025 Programs
Standard Uranium Ltd. (TSXV: STND,OTC:STTDF) (OTCQB: STTDF) (FSE: 9SU0) (‘Standard Uranium’ or the ‘Company’) is pleased to outline extensive exploration plans...
Sranan Gold Intersects 64 Metres Grading 3.0 g/t Including 33.5 g/t over 5 Metres at the Randy’s Pit Target at Tapanahony Project, Suriname, as First Holes Intersect a Significant Gold System
Sranan Gold Corp. (CSE: SRAN) (FSE: P84) (Tradegate: P84) (‘Sranan’ or the ‘Company’) announces significant diamond drill results from the...
Skyharbour’s Partner Mustang Energy Corp. Announces Results of TDEM Survey Over the 914W Property
Skyharbour Resources Ltd . (TSX-V: SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) (‘Skyharbour’ or the ‘Company’) is pleased to...
Finlay Minerals completes the 2025 Exploration Programs on the PIL and ATTY Toodoggone Projects
finlay minerals ltd. (TSXV: FYL,OTC:FYMNF) (OTCQB: FYMNF) (‘Finlay’ or the ‘Company’) is pleased to announce the completion of the 2025...
S&P 500 Breaking Out Again: What This Means for Your Portfolio
The S&P 500 ($SPX) just logged its fifth straight trading box breakout, which means that, of the five trading ranges the...
CHARBONE Appoints Patrick Cuddihy as Senior Vice President – Strategic Affairs
(TheNewswire) Brossard, Quebec, November 5, 2025 TheNewswire – CHARBONE CORPORATION (TSXV: CH,OTC:CHHYF; OTCQB: CHHYF; FSE: K47) (‘ CHARBONE ‘ or...
TERRA CLEAN CLOSES $2.5 MILLION LIFE OFFERING
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Terra Clean Energy CORP....
Noble Minerals Acquires a Rare Earth Property in Northern Quebec
(TheNewswire) Toronto, Ontario November 5, 2025 TheNewswire – Noble Mineral Exploration Inc. ( ‘Noble’ or the ‘Company’ ) (TSX-V:NOB, FRANKFURT:...
Cardiol Therapeutics’ Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
The ESC M&PD meeting brings together the world’s experts working to improve the treatment of myocarditis and pericarditis. Presentation to...
